Loading…
Reported covered position: Health Legislative Assistant - Senator Joe Lieberman. May 2011 - June 2012 Senior Legislative Assistant - Congressman Dan Boren. July 2008 - June 2011
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Monitored congressional efforts around the SACKLER Act, including H.R. 2096 / S. 2472 and HR 4777 / S 2497, including outreach regarding potential committee activity on the legislation.
Monitored congressional efforts around the SACKLER Act, including H.R. 2096 / S. 2472 and HR 4777 / S 2497, including outreach regarding potential committee activity on the legislation.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
TRISALUS LIFE SCIENCES via CAPITOL HILL CONSULTING GROUP
2022 · second_quarter · Q2
Medicare and Medicaid reimbursement issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BRE PROGRAM ADMINISTRATIVE SERVICES, LLC via CAPITOL HILL CONSULTING GROUP
2022 · second_quarter · Q2
Source: Senate LDA
| AMERICAN CHIROPRACTIC ASSOCIATION, INC. |
| 17 |
| 2018–2022 |
| UNITED STATES PHARMACOPEIAL CONVENTION (USP) | 15 | 2019–2022 |
| AMERICAN HEART ASSOCIATION | 11 | 2018–2020 |
| COHERUS BIOSCIENCES, INC | 11 | 2020–2022 |
| HEALTHSTAR, LLC | 11 | 2017–2019 |
| TEVA PHARMACEUTICALS USA | 11 | 2020–2022 |
| NOVARTIS CORPORATION | 8 | 2017–2018 |
| BRE PROGRAM ADMINISTRATIVE SERVICES, LLC | 6 | 2021–2022 |
| ENDO PHARMACEUTICALS | 6 | 2017–2018 |
| ALLIED BIOSCIENCE, INC. | 4 | 2021 |
| TRISALUS LIFE SCIENCES | 4 | 2021–2022 |
Resident Physician Shortage Reduction Act of 2021
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education including H.R. 2256/ S. 834, Issues related to price transparency. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund. Issues related to training of rural physicians including H.R. 4970. Issues related to extension of Medicare sequester. Issues related to telehealth.
Resident Physician Shortage Reduction Act of 2021
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education including H.R. 2256/ S. 834, Issues related to price transparency. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund. Issues related to training of rural physicians including H.R. 4970. Issues related to extension of Medicare sequester. Issues related to telehealth. Issues related to lab-developed tests in academic medical centers.
To amend title 38, United States Code, to clarify the role of doctors of podiatric medicine in the Department of Veterans Affairs, and for other purposes.
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues to clarify the VA Provider Equity Act including H.R. 2545 and S 2787. Expanded services through the Veterans Affairs Administration.
To amend title 38, United States Code, to clarify the role of doctors of podiatric medicine in the Department of Veterans Affairs, and for other purposes.
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues to clarify the VA Provider Equity Act including H.R. 2545 and S 2787. Expanded services through the Veterans Affairs Administration.
Chiropractic Medicare Coverage Modernization Act of 2021
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R. 2654 and S. 4042. Issues related to coronavirus, including regulatory flexibility for providers. Issues related to expanding access through telehealth. Issues related to the HHS Provider Relief Fund. Issues related to physician reimbursement.
Chiropractic Medicare Coverage Modernization Act of 2021
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R. 2654 and S. 4042. Issues related to coronavirus, including regulatory flexibility for providers. Issues related to expanding access through telehealth. Issues related to the HHS Provider Relief Fund. Issues related to physician reimbursement.
Nondebtor Release Prohibition Act of 2021
Client: PURDUE PHARMA LLP · Firm: CAPITOL HILL CONSULTING GROUP
Monitored congressional efforts around the SACKLER Act, including H.R. 2096 / S. 2472 and HR 4777 / S 2497, including outreach regarding potential committee activity on the legislation.
Nondebtor Release Prohibition Act of 2021
Client: PURDUE PHARMA LLP · Firm: CAPITOL HILL CONSULTING GROUP
Monitored congressional efforts around the SACKLER Act, including H.R. 2096 / S. 2472 and HR 4777 / S 2497, including outreach regarding potential committee activity on the legislation.
Rural Medical Residency Expansion Act of 2021
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education including H.R. 2256/ S. 834, Issues related to price transparency. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund. Issues related to training of rural physicians including H.R. 4970. Issues related to extension of Medicare sequester. Issues related to telehealth.
Rural Medical Residency Expansion Act of 2021
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education including H.R. 2256/ S. 834, Issues related to price transparency. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund. Issues related to training of rural physicians including H.R. 4970. Issues related to extension of Medicare sequester. Issues related to telehealth. Issues related to lab-developed tests in academic medical centers.
Monitored congressional efforts around the SACKLER Act, including H.R. 2096 / S. 2472 and HR 4777 / S 2497, including outreach regarding potential committee activity on the legislation.
Monitored congressional efforts around the SACKLER Act, including H.R. 2096 / S. 2472 and HR 4777 / S 2497, including outreach regarding potential committee activity on the legislation.
Nondebtor Release Prohibition Act of 2021
Client: PURDUE PHARMA LLP · Firm: CAPITOL HILL CONSULTING GROUP
Monitored congressional efforts around the SACKLER Act, including H.R. 2096 / S. 2472 and HR 4777 / S 2497, including outreach regarding potential committee activity on the legislation.
Nondebtor Release Prohibition Act of 2021
Client: PURDUE PHARMA LLP · Firm: CAPITOL HILL CONSULTING GROUP
Monitored congressional efforts around the SACKLER Act, including H.R. 2096 / S. 2472 and HR 4777 / S 2497, including outreach regarding potential committee activity on the legislation.
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to reintroduction of H.R. 2235 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians S. 2769 (HELLPP) Act. Issues related to therapeutic shoes. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund Issues regarding physician reimbursement
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to reintroduction of H.R. 2235 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians S. 2769 (HELLPP) Act. Issues related to therapeutic shoes. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund Issues regarding physician reimbursement
A bill to amend title 38, United States Code, to clarify the role of doctors of podiatric medicine in the Department of Veterans Affairs, and for other purposes.
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues to clarify the VA Provider Equity Act including H.R. 2545 and S 2787. Expanded services through the Veterans Affairs Administration.
A bill to amend title 38, United States Code, to clarify the role of doctors of podiatric medicine in the Department of Veterans Affairs, and for other purposes.
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues to clarify the VA Provider Equity Act including H.R. 2545 and S 2787. Expanded services through the Veterans Affairs Administration.
Chiropractic Medicare Coverage Modernization Act of 2022
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R. 2654 and S. 4042. Issues related to coronavirus, including regulatory flexibility for providers. Issues related to expanding access through telehealth. Issues related to the HHS Provider Relief Fund. Issues related to physician reimbursement.
Chiropractic Medicare Coverage Modernization Act of 2022
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R. 2654 and S. 4042. Issues related to coronavirus, including regulatory flexibility for providers. Issues related to expanding access through telehealth. Issues related to the HHS Provider Relief Fund. Issues related to physician reimbursement.
Resident Physician Shortage Reduction Act of 2021
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education including H.R. 2256/ S. 834, Issues related to price transparency. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund. Issues related to training of rural physicians including H.R. 4970. Issues related to extension of Medicare sequester. Issues related to telehealth. Issues related to lab-developed tests in academic medical centers.
Resident Physician Shortage Reduction Act of 2021
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education including H.R. 2256/ S. 834, Issues related to price transparency. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund. Issues related to training of rural physicians including H.R. 4970. Issues related to extension of Medicare sequester. Issues related to telehealth.
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to reintroduction of H.R. 2235 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians S. 2769 (HELLPP) Act. Issues related to therapeutic shoes. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund Issues regarding physician reimbursement
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to reintroduction of H.R. 2235 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians S. 2769 (HELLPP) Act. Issues related to therapeutic shoes. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund Issues regarding physician reimbursement
BRIDGE for Workers Act
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education. Issues related to price transparency. Issues related to H.R. 1763. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund.
Monitored congressional efforts around the SACKLER Act, including H.R. 2096 / S. 2472 and HR 4777 / S 2497, including outreach regarding potential committee activity on the legislation.
Monitored congressional efforts around the SACKLER Act, including H.R. 2096 / S. 2472 and HR 4777 / S 2497, including outreach regarding potential committee activity on the legislation.
Resident Physician Shortage Reduction Act of 2021
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education including H.R. 2256/ S. 834, Issues related to price transparency. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund. Issues related to training of rural physicians including H.R. 4970. Issues related to extension of Medicare sequester.
Resident Physician Shortage Reduction Act of 2021
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education including H.R. 2256/ S. 834, Issues related to price transparency. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund. Issues related to training of rural physicians including H.R. 4970.
Resident Physician Shortage Reduction Act of 2021
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education including H.R. 2256. Issues related to price transparency. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund.
To amend title 38, United States Code, to clarify the role of doctors of podiatric medicine in the Department of Veterans Affairs, and for other purposes.
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues to clarify the VA Provider Equity Act including H.R. 2545 and S 2787.
To amend title 38, United States Code, to clarify the role of doctors of podiatric medicine in the Department of Veterans Affairs, and for other purposes.
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues to clarify the VA Provider Equity Act including H.R. 2545 and S 2787.
Chiropractic Medicare Coverage Modernization Act of 2021
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R. 2654. Issues related to coronavirus, including regulatory flexibility for providers. Issues related to expanding access through telehealth. Issues related to the HHS Provider Relief Fund. Issues related to physician reimbursement.
Chiropractic Medicare Coverage Modernization Act of 2021
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R. 2654. Issues related to coronavirus, including regulatory flexibility for providers. Issues related to expanding access through telehealth. Issues related to the HHS Provider Relief Fund. Issues related to physician reimbursement.
Nondebtor Release Prohibition Act of 2021
Client: PURDUE PHARMA LLP · Firm: CAPITOL HILL CONSULTING GROUP
Monitored congressional efforts around the SACKLER Act, including H.R. 2096 / S. 2472 and HR 4777 / S 2497, including outreach regarding potential committee activity on the legislation.
Nondebtor Release Prohibition Act of 2021
Client: PURDUE PHARMA LLP · Firm: CAPITOL HILL CONSULTING GROUP
Monitored congressional efforts around the SACKLER Act, including H.R. 2096 / S. 2472 and HR 4777 / S 2497, including outreach regarding potential committee activity on the legislation.
Rural Medical Residency Expansion Act of 2021
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education including H.R. 2256/ S. 834, Issues related to price transparency. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund. Issues related to training of rural physicians including H.R. 4970. Issues related to extension of Medicare sequester.
Rural Medical Residency Expansion Act of 2021
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education including H.R. 2256/ S. 834, Issues related to price transparency. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund. Issues related to training of rural physicians including H.R. 4970.
Monitored congressional efforts around the SACKLER Act, including H.R. 2096 / S. 2472 and HR 4777 / S 2497, including outreach regarding potential committee activity on the legislation.
Monitored congressional efforts around the SACKLER Act, including H.R. 2096 / S. 2472 and HR 4777 / S 2497, including outreach regarding potential committee activity on the legislation.
Nondebtor Release Prohibition Act of 2021
Client: PURDUE PHARMA LLP · Firm: CAPITOL HILL CONSULTING GROUP
Monitored congressional efforts around the SACKLER Act, including H.R. 2096 / S. 2472 and HR 4777 / S 2497, including outreach regarding potential committee activity on the legislation.
Nondebtor Release Prohibition Act of 2021
Client: PURDUE PHARMA LLP · Firm: CAPITOL HILL CONSULTING GROUP
Monitored congressional efforts around the SACKLER Act, including H.R. 2096 / S. 2472 and HR 4777 / S 2497, including outreach regarding potential committee activity on the legislation.
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to reintroduction of H.R. 2235 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians S. 2769 (HELLPP) Act. Issues related to therapeutic shoes. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund Issues regarding physician reimbursement
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to reintroduction of H.R. 2235 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians S. 2769 (HELLPP) Act. Issues related to therapeutic shoes. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund Issues regarding physician reimbursement
A bill to amend title 38, United States Code, to clarify the role of doctors of podiatric medicine in the Department of Veterans Affairs, and for other purposes.
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues to clarify the VA Provider Equity Act including H.R. 2545 and S 2787.
A bill to amend title 38, United States Code, to clarify the role of doctors of podiatric medicine in the Department of Veterans Affairs, and for other purposes.
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues to clarify the VA Provider Equity Act including H.R. 2545 and S 2787.
Resident Physician Shortage Reduction Act of 2021
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education including H.R. 2256/ S. 834, Issues related to price transparency. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund. Issues related to training of rural physicians including H.R. 4970.
Resident Physician Shortage Reduction Act of 2021
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education including H.R. 2256/ S. 834, Issues related to price transparency. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund. Issues related to training of rural physicians including H.R. 4970. Issues related to extension of Medicare sequester.
Asylum Abuse Reduction Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to S. 863 to clarify the VA Provider Equity Act.
Asylum Abuse Reduction Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to S. 863 to clarify the VA Provider Equity Act.
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to reintroduction of H.R. 2235 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians S. 2769 (HELLPP) Act. Issues related to therapeutic shoes. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund Issues regarding physician reimbursement
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to reintroduction of H.R. 2235 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act. Issues related to therapeutic shoes. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund Issues regarding physician reimbursement
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to reintroduction of H.R. 2235 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians S. 2769 (HELLPP) Act. Issues related to therapeutic shoes. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund Issues regarding physician reimbursement
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to reintroduction of H.R. 2235 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act. Issues related to therapeutic shoes. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund Issues regarding physician reimbursement
Saving America’s Pollinators Act of 2019
Client: AMERICAN HEART ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
HR 1337, increasing charitable giving via IRA.
Saving America’s Pollinators Act of 2019
Client: AMERICAN HEART ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
HR 1337, increasing charitable giving via IRA.
Resident Physician Shortage Reduction Act of 2019
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education.Issues related to price transparency. Issues related to H.R. 1763. Issues related to coronavirus, including funding and regulatory flexibility for providers.
Resident Physician Shortage Reduction Act of 2019
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education.Issues related to price transparency. Issues related to H.R. 1763. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund.
Resident Physician Shortage Reduction Act of 2019
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education.Issues related to price transparency. Issues related to H.R. 1763. Issues related to coronavirus, including funding and regulatory flexibility for providers.
Resident Physician Shortage Reduction Act of 2019
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education.Issues related to price transparency. Issues related to H.R. 1763. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund.
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to H.R. 2235 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act. Issues related to therapeutic shoes. Issues related to coronavirus, including funding and regulatory flexibility for providers.
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to H.R. 2235 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act. Issues related to therapeutic shoes. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund Issues regarding physician reimbursement
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to H.R. 2235 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act. Issues related to therapeutic shoes.Issues related to coronavirus, including funding and regulatory flexibility for providers.
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to H.R. 2235 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act. Issues related to therapeutic shoes. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund Issues regarding physician reimbursement
Opioid Workforce Act of 2019
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to prescription of opioids, including HR 2439, Opioid Workforce Act. Issues related to the cost of health coverage; Issues related to Surprise Billing;
Chiropractic Medicare Coverage Modernization Act of 2019
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R. 3654. Issues related to coronavirus, including regulatory flexibility for providers. Issues related to expanding access through telehealth. Issues related to the HHS Provider Relief Fund. Issues related to physician reimbursement.
Chiropractic Medicare Coverage Modernization Act of 2019
Client: AMERICAN CHIROPRACTIC ASSOCIATION, INC. · Firm: CAPITOL HILL CONSULTING GROUP
Medicare reimbursement and coverage of chiropractic services, including H.R. 3654. Issues related to coronavirus, including regulatory flexibility for providers. Issues related to expanding access through telehealth. Issues related to the HHS Provider Relief Fund.
Increasing Access to Quality Cardiac Rehabilitation Care Act of 2019
Client: AMERICAN HEART ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to cardiac rehabilitation coverage, including HR 3911 and S. 2842. Issues related to coronavirus, including regulatory flexibility for providers.
Increasing Access to Quality Cardiac Rehabilitation Care Act of 2019
Client: AMERICAN HEART ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to cardiac rehabilitation coverage, including HR 3911 and S. 2842. Issues related to coronavirus, including regulatory flexibility for providers.
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Issues related to improvement of chronic disease. Issues surrounding H.R. 8254 / S. 4574 the BETTER Kidney Care Act Issues related to the HHS Provider Relief Fund.
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Issues related to improvement of chronic disease. Issues surrounding H.R. 8254 / S. 4574 the BETTER Kidney Care Act Issues related to the HHS Provider Relief Fund.
Increasing Access to Quality Cardiac Rehabilitation Care Act of 2019
Client: AMERICAN HEART ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to cardiac rehabilitation coverage, including HR 3911 and S. 2842. Issues related to coronavirus, including regulatory flexibility for providers.
Increasing Access to Quality Cardiac Rehabilitation Care Act of 2019
Client: AMERICAN HEART ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to cardiac rehabilitation coverage, including HR 3911 and S. 2842. Issues related to coronavirus, including regulatory flexibility for providers.
Bringing Enhanced Treatments and Therapies to ESRD Recipients (BETTER) Kidney Care Act
Client: DAVITA INC · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Issues related to improvement of chronic disease. Issues surrounding H.R. 8254 / S. 4574 the BETTER Kidney Care Act Issues related to the HHS Provider Relief Fund.
Bringing Enhanced Treatments and Therapies to ESRD Recipients (BETTER) Kidney Care Act
Client: DAVITA INC · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Issues related to improvement of chronic disease. Issues surrounding H.R. 8254 / S. 4574 the BETTER Kidney Care Act Issues related to the HHS Provider Relief Fund.
A bill to amend title 38, United States Code, to clarify the grade and pay of podiatrists of the Department of Veterans Affairs.
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to S. 863 to clarify the VA Provider Equity Act
A bill to amend title 38, United States Code, to clarify the grade and pay of podiatrists of the Department of Veterans Affairs.
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to S. 863 to clarify the VA Provider Equity Act
A bill to amend title 38, United States Code, to clarify the grade and pay of podiatrists of the Department of Veterans Affairs.
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to S. 863 to clarify the VA Provider Equity Act
A bill to amend title 38, United States Code, to clarify the grade and pay of podiatrists of the Department of Veterans Affairs.
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to S. 863 to clarify the VA Provider Equity Act
Saving America’s Pollinators Act of 2019
Client: AMERICAN HEART ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
HR 1337, increasing charitable giving via IRA.
Saving America’s Pollinators Act of 2019
Client: AMERICAN HEART ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
HR 1337, increasing charitable giving via IRA.
Saving America’s Pollinators Act of 2019
Client: AMERICAN HEART ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
HR 1337, increasing charitable giving via IRA.
Saving America’s Pollinators Act of 2019
Client: AMERICAN HEART ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
HR 1337, increasing charitable giving via IRA.
Resident Physician Shortage Reduction Act of 2019
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education.Issues related to price transparency. Issues related to H.R. 1763
Resident Physician Shortage Reduction Act of 2019
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education.Issues related to price transparency. Issues related to H.R. 1763
Resident Physician Shortage Reduction Act of 2019
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education.Issues related to price transparency. Issues related to H.R. 1763
Resident Physician Shortage Reduction Act of 2019
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to Graduate Medical Education.Issues related to price transparency. Issues related to H.R. 1763
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to H.R. 2235 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act.
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to H.R. 2235 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act. Issues related to therapeutic shoes.
HELLPP Act
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to H.R. 2235 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act.
Opioid Workforce Act of 2019
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to prescription of opioids, including HR 2439, Opioid Workforce Act. Issues related to the cost of health coverage; Issues related to Surprise Billing;
Opioid Workforce Act of 2019
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to prescription of opioids, including HR 2439, Opioid Workforce Act. Issues related to the cost of health coverage; Issues related to Surprise Billing;
Opioid Workforce Act of 2019
Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to prescription of opioids, including HR 2439, Opioid Workforce Act. Issues related to the cost of health coverage; Issues related to Surprise Billing;
Increasing Access to Quality Cardiac Rehabilitation Care Act of 2019
Client: AMERICAN HEART ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to cardiac rehabilitation coverage, including HR 3911 and S. 2842.
Increasing Access to Quality Cardiac Rehabilitation Care Act of 2019
Client: AMERICAN HEART ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to cardiac rehabilitation coverage, including HR 3911.
Increasing Access to Quality Cardiac Rehabilitation Care Act of 2019
Client: AMERICAN HEART ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to cardiac rehabilitation coverage, including HR 3911 and S. 2842.
A bill to amend title 38, United States Code, to clarify the grade and pay of podiatrists of the Department of Veterans Affairs.
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to S. 863 to clarify the VA Provider Equity Act
A bill to amend title 38, United States Code, to clarify the grade and pay of podiatrists of the Department of Veterans Affairs.
Client: AMERICAN PODIATRIC MEDICAL ASSOCIATION · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to S. 863 to clarify the VA Provider Equity Act
Access to mental health care and Centers for Medicare and Medicaid Services payment policy. Issues related to prior authorization.
Access to mental health care and Centers for Medicare and Medicaid Services payment policy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COHERUS BIOSCIENCES, INC via CAPITOL HILL CONSULTING GROUP
2022 · second_quarter · Q2
Medicare and Medicaid reimbursement for biosimilars, including for domestically manufactured biosimilars. Issues relating to the impact of prescription drug negotiation on biosimilars.
Biosimilar User Fee Act (BSUFA).
Issues surrounding the US pharmaceutical supply chain.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Security Council (NSC), SENATE
TEVA PHARMACEUTICALS USA via CAPITOL HILL CONSULTING GROUP
2022 · second_quarter · Q2
Generic Drug User Fee Amendments(GDUFA).
Issues surrounding Medicare reimbursement of generic drugs and biosimilars. Issues relating to the impact of prescription drug negotiation on generic drugs.
Issues surrounding US Pharmaceutical supply chain. Issues surrounding the generic drug and biosimilar user free agreements. Issues surrounding the regulation of complex generic drugs. HHS and National Security Council for agencies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES PHARMACOPEIAL CONVENTION (USP) via CAPITOL HILL CONSULTING GROUP
2022 · second_quarter · Q2
Maintaining US support for quality pharmaceutical standards. Issues related to coronavirus, including drug and supply chain safety. Issues related to continuous manufacturing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
AMERICAN CHIROPRACTIC ASSOCIATION, INC. via CAPITOL HILL CONSULTING GROUP
2022 · second_quarter · Q2
Medicare reimbursement and coverage of chiropractic services, including H.R. 2654 and S. 4042. Issues related to coronavirus, including regulatory flexibility for providers. Issues related to expanding access through telehealth. Issues related to the HHS Provider Relief Fund. Issues related to physician reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN PODIATRIC MEDICAL ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2022 · second_quarter · Q2
Issues to clarify the VA Provider Equity Act including H.R. 2545 and S 2787. Expanded services through the Veterans Affairs Administration.
Issues related to reintroduction of H.R. 2235 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians S. 2769 (HELLPP) Act. Issues related to therapeutic shoes. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund Issues regarding physician reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
ASSOCIATION OF AMERICAN MEDICAL COLLEGES via CAPITOL HILL CONSULTING GROUP
2022 · second_quarter · Q2
Issues related to hospital reimbursement during Covid-19 pandemic.
Issues related to Graduate Medical Education including H.R. 2256/ S. 834, Issues related to price transparency. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund. Issues related to training of rural physicians including H.R. 4970. Issues related to extension of Medicare sequester. Issues related to telehealth. Issues related to lab-developed tests in academic medical centers.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY GENERIC PHARMACEUTICAL ASSOC.) via CAPITOL HILL CONSULTING GROUP
2022 · second_quarter · Q2
Provisions from the Bipartisan Budget Act of 2015 concerning the Medicaid rebate program. Issues related to the Medicare low-income subsidy. Issues related to the cost of prescription drugs. Issues pertaining to coverage and reimbursement of biosimilars. Issues related to Part D coverage of generic drugs, including Part D redesign. Issues relating to the impact of prescription drug negotiation on generic drugs and biosimilars. Issues related to Medicare Part D reform Issues surrounding the generic drug and biosimilar user fee agreements. Issues surrounding the generic drug and biosimilar user fee agreements.
Issues related to Buy American.
CVS PREVIOUSLY AETNA via CAPITOL HILL CONSULTING GROUP
2022 · second_quarter · Q2
Issues pertaining to entitlement reform, Medicare Advantage, Medicaid Dual Eligibles, and Medicare reimbursement and enrollment; Issues related to Drug Pricing and rebates, including Part D reform. Issues related to coronavirus response. Issues related to pharmacy benefit managers
Medicare advantage payment policy. Issues related to the federal response to Covid-19.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA INC via CAPITOL HILL CONSULTING GROUP
2022 · second_quarter · Q2
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Issues surrounding the reintroduction of BETTER Kidney Care Act. Issues related to application of Medicare Secondary Payer. Issues related to Medicare Secondary Payer.
Issues related to the response of the COVID-19 virus and access to vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2022 · second_quarter · Q2
Monitoring for issues and hearing related to prevention of abuse, misuse or diversion of prescription drugs; federal response to the COVID-19 crisis; prescription drug payment reform; and pharmaceutical supply chain.
Monitored congressional efforts around the SACKLER Act, including H.R. 2096 / S. 2472 and HR 4777 / S 2497, including outreach regarding potential committee activity on the legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via CAPITOL HILL CONSULTING GROUP
2022 · first_quarter · Q1
Medicare and Medicaid reimbursement issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BRE PROGRAM ADMINISTRATIVE SERVICES, LLC via CAPITOL HILL CONSULTING GROUP
2022 · first_quarter · Q1
Access to mental health care and Centers for Medicare and Medicaid Services payment policy. Issues related to prior authorization.
Access to mental health care and Centers for Medicare and Medicaid Services payment policy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COHERUS BIOSCIENCES, INC via CAPITOL HILL CONSULTING GROUP
2022 · first_quarter · Q1
Issues surrounding the US pharmaceutical supply chain.
Medicare and Medicaid reimbursement for biosimilars, including for domestically manufactured biosimilars. Issues relating to the impact of prescription drug negotiation on biosimilars.
Biosimilar User Fee Act (BSUFA).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Security Council (NSC), SENATE
TEVA PHARMACEUTICALS USA via CAPITOL HILL CONSULTING GROUP
2022 · first_quarter · 1A
Issues surrounding Medicare reimbursement of generic drugs and biosimilars. Issues relating to the impact of prescription drug negotiation on generic drugs.
Issues surrounding US Pharmaceutical supply chain. Issues surrounding the generic drug and biosimilar user free agreements. Issues surrounding the regulation of complex generic drugs. HHS and National Security Council for agencies.
Generic Drug User Fee Amendments(GDUFA).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEVA PHARMACEUTICALS USA via CAPITOL HILL CONSULTING GROUP
2022 · first_quarter · Q1
Generic Drug User Fee Amendments(GDUFA).
Issues surrounding Medicare reimbursement of generic drugs and biosimilars. Issues relating to the impact of prescription drug negotiation on generic drugs.
Issues surrounding US Pharmaceutical supply chain. Issues surrounding the generic drug and biosimilar user free agreements. Issues surrounding the regulation of complex generic drugs. HHS and National Security Council for agencies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES PHARMACOPEIAL CONVENTION (USP) via CAPITOL HILL CONSULTING GROUP
2022 · first_quarter · Q1
Maintaining US support for quality pharmaceutical standards. Issues related to coronavirus, including drug and supply chain safety. Issues related to continuous manufacturing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
AMERICAN CHIROPRACTIC ASSOCIATION, INC. via CAPITOL HILL CONSULTING GROUP
2022 · first_quarter · Q1
Medicare reimbursement and coverage of chiropractic services, including H.R. 2654 and S. 4042. Issues related to coronavirus, including regulatory flexibility for providers. Issues related to expanding access through telehealth. Issues related to the HHS Provider Relief Fund. Issues related to physician reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN PODIATRIC MEDICAL ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2022 · first_quarter · Q1
Issues related to reintroduction of H.R. 2235 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians S. 2769 (HELLPP) Act. Issues related to therapeutic shoes. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund Issues regarding physician reimbursement
Issues to clarify the VA Provider Equity Act including H.R. 2545 and S 2787. Expanded services through the Veterans Affairs Administration.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
ASSOCIATION OF AMERICAN MEDICAL COLLEGES via CAPITOL HILL CONSULTING GROUP
2022 · first_quarter · Q1
Issues related to Graduate Medical Education including H.R. 2256/ S. 834, Issues related to price transparency. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund. Issues related to training of rural physicians including H.R. 4970. Issues related to extension of Medicare sequester. Issues related to telehealth.
Issues related to hospital reimbursement during Covid-19 pandemic.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY GENERIC PHARMACEUTICAL ASSOC.) via CAPITOL HILL CONSULTING GROUP
2022 · first_quarter · Q1
Generic Drug User Fee Amendments (GDUFA)
- Issues relating to the labeling of generic drugs. - Issues relating to the 180 day exclusivity for generics. - Issues related to coronavirus, including supply chain safety.
Provisions from the Bipartisan Budget Act of 2015 concerning the Medicaid rebate program. Issues related to the Medicare low-income subsidy. Issues related to the cost of prescription drugs. Issues pertaining to coverage and reimbursement of biosimilars. Issues related to Part D coverage of generic drugs, including Part D redesign. Issues relating to the impact of prescription drug negotiation on generic drugs and biosimilars.
CVS PREVIOUSLY AETNA via CAPITOL HILL CONSULTING GROUP
2022 · first_quarter · Q1
Issues pertaining to entitlement reform, Medicare Advantage, Medicaid Dual Eligibles, and Medicare reimbursement and enrollment; Issues related to Drug Pricing and rebates, including Part D reform. Issues related to coronavirus response.
Medicare advantage payment policy. Issues related to the federal response to Covid-19.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA INC via CAPITOL HILL CONSULTING GROUP
2022 · first_quarter · Q1
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Issues surrounding the reintroduction of BETTER Kidney Care Act. Issues related to application of Medicare Secondary Payer. Issues related to Medicare Secondary Payer.
Issues related to the response of the COVID-19 virus and access to vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2022 · first_quarter · Q1
Monitored congressional efforts around the SACKLER Act, including H.R. 2096 / S. 2472 and HR 4777 / S 2497, including outreach regarding potential committee activity on the legislation.
Monitoring for issues and hearing related to prevention of abuse, misuse or diversion of prescription drugs; federal response to the COVID-19 crisis; prescription drug payment reform; and pharmaceutical supply chain.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRISALUS LIFE SCIENCES via CAPITOL HILL CONSULTING GROUP
2021 · fourth_quarter · Q4
Medicare and Medicaid reimbursement issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TRISALUS LIFE SCIENCES via CAPITOL HILL CONSULTING GROUP
2021 · fourth_quarter · RR
Medicare and Medicaid reimbursement issues.
BRE PROGRAM ADMINISTRATIVE SERVICES, LLC via CAPITOL HILL CONSULTING GROUP
2021 · fourth_quarter · Q4
Access to mental health care and Centers for Medicare and Medicaid Services payment policy. Issues related to prior authorization.
Access to mental health care and Centers for Medicare and Medicaid Services payment policy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COHERUS BIOSCIENCES, INC via CAPITOL HILL CONSULTING GROUP
2021 · fourth_quarter · Q4
Issues surrounding the US pharmaceutical supply chain.
Medicare and Medicaid reimbursement for biosimilars, including for domestically manufactured biosimilars. Issues relating to the impact of prescription drug negotiation on biosimilars.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Security Council (NSC), SENATE
TEVA PHARMACEUTICALS USA via CAPITOL HILL CONSULTING GROUP
2021 · fourth_quarter · Q4
Issues surrounding Medicare reimbursement of generic drugs and biosimilars. Issues relating to the impact of prescription drug negotiation on generic drugs.
Issues surrounding US Pharmaceutical supply chain. Issues surrounding the generic drug and biosimilar user free agreements. Issues surrounding the regulation of complex generic drugs. HHS and National Security Council for agencies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES PHARMACOPEIAL CONVENTION (USP) via CAPITOL HILL CONSULTING GROUP
2021 · fourth_quarter · Q4
Maintaining US support for quality pharmaceutical standards. Issues related to coronavirus, including drug and supply chain safety. Issues related to continuous manufacturing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2021 · fourth_quarter · Q4
Monitored congressional efforts around the SACKLER Act, including H.R. 2096 / S. 2472 and HR 4777 / S 2497, including outreach regarding potential committee activity on the legislation.
Monitoring for issues and hearing related to prevention of abuse, misuse or diversion of prescription drugs; federal response to the COVID-19 crisis; prescription drug payment reform; and pharmaceutical supply chain.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CHIROPRACTIC ASSOCIATION, INC. via CAPITOL HILL CONSULTING GROUP
2021 · fourth_quarter · Q4
Medicare reimbursement and coverage of chiropractic services, including H.R. 2654. Issues related to coronavirus, including regulatory flexibility for providers. Issues related to expanding access through telehealth. Issues related to the HHS Provider Relief Fund. Issues related to physician reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN PODIATRIC MEDICAL ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2021 · fourth_quarter · Q4
Issues to clarify the VA Provider Equity Act including H.R. 2545 and S 2787.
Issues related to reintroduction of H.R. 2235 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians S. 2769 (HELLPP) Act. Issues related to therapeutic shoes. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund Issues regarding physician reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASSOCIATION OF AMERICAN MEDICAL COLLEGES via CAPITOL HILL CONSULTING GROUP
2021 · fourth_quarter · Q4
Issues related to hospital reimbursement during Covid-19 pandemic.
Issues related to Graduate Medical Education including H.R. 2256/ S. 834, Issues related to price transparency. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund. Issues related to training of rural physicians including H.R. 4970. Issues related to extension of Medicare sequester.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY GENERIC PHARMACEUTICAL ASSOC.) via CAPITOL HILL CONSULTING GROUP
2021 · fourth_quarter · Q4
Provisions from the Bipartisan Budget Act of 2015 concerning the Medicaid rebate program. Issues related to the Medicare low-income subsidy. Issues related to the cost of prescription drugs. Issues pertaining to coverage and reimbursement of biosimilars. Issues related to Part D coverage of generic drugs, including Part D redesign. Issues relating to the impact of prescription drug negotiation on generic drugs and biosimilars.
Issues related to Buy American.
- Issues relating to the labeling of generic drugs. - Issues relating to the 180 day exclusivity for generics. - Issues related to coronavirus, including supply chain safety.
CVS PREVIOUSLY AETNA via CAPITOL HILL CONSULTING GROUP
2021 · fourth_quarter · Q4
Medicare advantage payment policy. Issues related to the federal response to Covid-19.
Issues pertaining to entitlement reform, Medicare Advantage, Medicaid Dual Eligibles, and Medicare reimbursement and enrollment; Issues related to Drug Pricing and rebates, including Part D reform. Issues related to coronavirus response.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA INC via CAPITOL HILL CONSULTING GROUP
2021 · fourth_quarter · Q4
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Issues surrounding the reintroduction of BETTER Kidney Care Act. Issues related to application of Medicare Secondary Payer. Issues related to Medicare Secondary Payer.
Issues related to the response of the COVID-19 virus and access to vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIED BIOSCIENCE, INC. via CAPITOL HILL CONSULTING GROUP
2021 · third_quarter · Q3
Regulatory Approved for Health Related Tech. Issues related to coronavirus response.
EPA Regulatory Approval. CARES Act implementation.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
ALLIED BIOSCIENCE, INC. via CAPITOL HILL CONSULTING GROUP
2021 · third_quarter · 3T
EPA Regulatory Approval. CARES Act implementation.
Regulatory Approved for Health Related Tech. Issues related to coronavirus response.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
BRE PROGRAM ADMINISTRATIVE SERVICES, LLC via CAPITOL HILL CONSULTING GROUP
2021 · third_quarter · Q3
Access to mental health care and Centers for Medicare and Medicaid Services payment policy.
Access to mental health care and Centers for Medicare and Medicaid Services payment policy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COHERUS BIOSCIENCES, INC via CAPITOL HILL CONSULTING GROUP
2021 · third_quarter · Q3
Issues surrounding the US pharmaceutical supply chain.
Medicare and Medicaid reimbursement for biosimilars, including for domestically manufactured biosimilars.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Security Council (NSC), SENATE
TEVA PHARMACEUTICALS USA via CAPITOL HILL CONSULTING GROUP
2021 · third_quarter · Q3
Issues surrounding Medicare reimbursement of generic drugs and biosimilars.
Issues surrounding US Pharmaceutical supply chain. Issues surrounding the generic drug and biosimilar user free agreements. Issues surrounding the regulation of complex generic drugs. HHS and National Security Council for agencies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES PHARMACOPEIAL CONVENTION (USP) via CAPITOL HILL CONSULTING GROUP
2021 · third_quarter · Q3
Maintaining US support for quality pharmaceutical standards. Issues related to coronavirus, including drug and supply chain safety. Issues related to continuous manufacturing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
AMERICAN CHIROPRACTIC ASSOCIATION, INC. via CAPITOL HILL CONSULTING GROUP
2021 · third_quarter · Q3
Medicare reimbursement and coverage of chiropractic services, including H.R. 2654. Issues related to coronavirus, including regulatory flexibility for providers. Issues related to expanding access through telehealth. Issues related to the HHS Provider Relief Fund. Issues related to physician reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN PODIATRIC MEDICAL ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2021 · third_quarter · Q3
Issues related to reintroduction of H.R. 2235 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians S. 2769 (HELLPP) Act. Issues related to therapeutic shoes. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund Issues regarding physician reimbursement
Issues to clarify the VA Provider Equity Act including H.R. 2545 and S 2787.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CVS PREVIOUSLY AETNA via CAPITOL HILL CONSULTING GROUP
2021 · third_quarter · Q3
Issues pertaining to entitlement reform, Medicare Advantage, Medicaid Dual Eligibles, and Medicare reimbursement and enrollment; Issues related to Drug Pricing and rebates, including Part D reform. Issues related to coronavirus response.
Medicare advantage payment policy. Issues related to the federal response to Covid-19.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF AMERICAN MEDICAL COLLEGES via CAPITOL HILL CONSULTING GROUP
2021 · third_quarter · Q3
Issues related to hospital reimbursement during Covid-19 pandemic.
Issues related to Graduate Medical Education including H.R. 2256/ S. 834, Issues related to price transparency. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund. Issues related to training of rural physicians including H.R. 4970.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY GENERIC PHARMACEUTICAL ASSOC.) via CAPITOL HILL CONSULTING GROUP
2021 · third_quarter · Q3
Provisions from the Bipartisan Budget Act of 2015 concerning the Medicaid rebate program. Issues related to the Medicare low-income subsidy. Issues related to the cost of prescription drugs. Issues pertaining to coverage and reimbursement of biosimilars. Issues related to Part D coverage of generic drugs, including Part D redesign.
Issues related to Buy American.
- Issues relating to the labeling of generic drugs. - Issues relating to the 180 day exclusivity for generics. - Issues related to coronavirus, including supply chain safety.
DAVITA INC via CAPITOL HILL CONSULTING GROUP
2021 · third_quarter · Q3
Issues related to the response of the COVID-19 virus and access to vaccines.
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Issues surrounding the reintroduction of BETTER Kidney Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2021 · third_quarter · Q3
Monitoring for issues and hearing related to prevention of abuse, misuse or diversion of prescription drugs; federal response to the COVID-19 crisis; prescription drug payment reform; and pharmaceutical supply chain.
Monitored congressional efforts around the SACKLER Act, including H.R. 2096 / S. 2472 and HR 4777 / S 2497, including outreach regarding potential committee activity on the legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY GENERIC PHARMACEUTICAL ASSOC.) via CAPITOL HILL CONSULTING GROUP
2021 · second_quarter · Q2
Issues related to Buy American.
- Issues relating to the labeling of generic drugs. - Issues relating to the 180 day exclusivity for generics. - Issues related to coronavirus, including supply chain safety.
Provisions from the Bipartisan Budget Act of 2015 concerning the Medicaid rebate program. Issues related to the Medicare low-income subsidy. Issues related to the cost of prescription drugs. Issues pertaining to coverage and reimbursement of biosimilars. Issues related to Part D coverage of generic drugs, including Part D redesign.
BRE PROGRAM ADMINISTRATIVE SERVICES, LLC via CAPITOL HILL CONSULTING GROUP
2021 · second_quarter · Q2
Access to mental health care and Centers for Medicare and Medicaid Services payment policy.
Access to mental health care and Centers for Medicare and Medicaid Services payment policy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIED BIOSCIENCE, INC. via CAPITOL HILL CONSULTING GROUP
2021 · second_quarter · Q2
Regulatory Approved for Health Related Tech. Issues related to coronavirus response.
EPA Regulatory Approval. CARES Act implementation.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
BRE PROGRAM ADMINISTRATIVE SERVICES, LLC via CAPITOL HILL CONSULTING GROUP
2021 · second_quarter · RR
Access to mental health care and Centers for Medicare and Medicaid Services payment policy.
Access to mental health care and Centers for Medicare and Medicaid Services payment policy.
COHERUS BIOSCIENCES, INC via CAPITOL HILL CONSULTING GROUP
2021 · second_quarter · Q2
Issues surrounding the US pharmaceutical supply chain.
Medicare and Medicaid reimbursement for biosimilars, including for domestically manufactured biosimilars.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Security Council (NSC), SENATE
TEVA PHARMACEUTICALS USA via CAPITOL HILL CONSULTING GROUP
2021 · second_quarter · Q2
Issues surrounding US Pharmaceutical supply chain. Issues surrounding the generic drug and biosimilar user free agreements. Issues surrounding the regulation of complex generic drugs. HHS and National Security Council for agencies.
Issues surrounding Medicare reimbursement of generic drugs and biosimilars.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES PHARMACOPEIAL CONVENTION (USP) via CAPITOL HILL CONSULTING GROUP
2021 · second_quarter · Q2
Maintaining US support for quality pharmaceutical standards. Issues related to coronavirus, including drug and supply chain safety. Issues related to continuous manufacturing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
AMERICAN CHIROPRACTIC ASSOCIATION, INC. via CAPITOL HILL CONSULTING GROUP
2021 · second_quarter · Q2
Medicare reimbursement and coverage of chiropractic services. Issues related to coronavirus, including regulatory flexibility for providers. Issues related to expanding access through telehealth. Issues related to the HHS Provider Relief Fund. Issues related to physician reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN PODIATRIC MEDICAL ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2021 · second_quarter · Q2
Issues related to S. 863 to clarify the VA Provider Equity Act.
Issues related to reintroduction of H.R. 2235 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act. Issues related to therapeutic shoes. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund Issues regarding physician reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CVS PREVIOUSLY AETNA via CAPITOL HILL CONSULTING GROUP
2021 · second_quarter · Q2
Medicare advantage payment policy. Issues related to the federal response to Covid-19.
Issues pertaining to entitlement reform, Medicare Advantage, Medicaid Dual Eligibles, and Medicare reimbursement and enrollment; Issues related to Drug Pricing and rebates, including Part D reform. Issues related to coronavirus response.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA INC via CAPITOL HILL CONSULTING GROUP
2021 · second_quarter · Q2
Issues related to the response of the COVID-19 virus and access to vaccines.
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Issues surrounding the reintroduction of BETTER Kidney Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2021 · second_quarter · Q2
Monitoring for issues and hearing related to prevention of abuse, misuse or diversion of prescription drugs; federal response to the COVID-19 crisis; prescription drug payment reform; and pharmaceutical supply chain.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF AMERICAN MEDICAL COLLEGES via CAPITOL HILL CONSULTING GROUP
2021 · second_quarter · Q2
Issues related to hospital reimbursement during Covid-19 pandemic.
Issues related to Graduate Medical Education including H.R. 2256. Issues related to price transparency. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COHERUS BIOSCIENCES, INC via CAPITOL HILL CONSULTING GROUP
2021 · first_quarter · Q1
Medicare and Medicaid reimbursement for biosimilars, including for domestically manufactured biosimilars.
Issues surrounding the US pharmaceutical supply chain.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Security Council (NSC), SENATE
TEVA PHARMACEUTICALS USA via CAPITOL HILL CONSULTING GROUP
2021 · first_quarter · Q1
Issues surrounding US Pharmaceutical supply chain. Issues surrounding the generic drug and biosimilar user free agreements. Issues surrounding the regulation of complex generic drugs. HHS and National Security Council for agencies.
Issues surrounding Medicare reimbursement of generic drugs and biosimilars.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES PHARMACOPEIAL CONVENTION (USP) via CAPITOL HILL CONSULTING GROUP
2021 · first_quarter · Q1
Maintaining US support for quality pharmaceutical standards. Issues related to coronavirus, including drug and supply chain safety. Issues related to continuous manufacturing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
AMERICAN CHIROPRACTIC ASSOCIATION, INC. via CAPITOL HILL CONSULTING GROUP
2021 · first_quarter · Q1
Medicare reimbursement and coverage of chiropractic services. Issues related to coronavirus, including regulatory flexibility for providers. Issues related to expanding access through telehealth. Issues related to the HHS Provider Relief Fund. Issues related to physician reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN PODIATRIC MEDICAL ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2021 · first_quarter · Q1
Issues related to reintroduction of H.R. 2235 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act. Issues related to therapeutic shoes. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund Issues regarding physician reimbursement
Issues related to S. 863 to clarify the VA Provider Equity Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIED BIOSCIENCE, INC. via CAPITOL HILL CONSULTING GROUP
2021 · first_quarter · Q1
Regulatory Approved for Health Related Tech. Issues related to coronavirus response.
EPA Regulatory Approval. CARES Act implementation.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF AMERICAN MEDICAL COLLEGES via CAPITOL HILL CONSULTING GROUP
2021 · first_quarter · Q1
Issues related to hospital reimbursement during Covid-19 pandemic.
Issues related to Graduate Medical Education. Issues related to price transparency. Issues related to H.R. 1763. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY GENERIC PHARMACEUTICAL ASSOC.) via CAPITOL HILL CONSULTING GROUP
2021 · first_quarter · Q1
- Issues relating to the labeling of generic drugs. - Issues relating to the 180 day exclusivity for generics. - Issues related to coronavirus, including supply chain safety.
Issues related to Buy American.
Provisions from the Bipartisan Budget Act of 2015 concerning the Medicaid rebate program. Issues related to the Medicare low-income subsidy. Issues related to the cost of prescription drugs. Issues pertaining to coverage and reimbursement of biosimilars. Issues related to Part D coverage of generic drugs, including Part D redesign.
CVS PREVIOUSLY AETNA via CAPITOL HILL CONSULTING GROUP
2021 · first_quarter · Q1
Issues pertaining to entitlement reform, Medicare Advantage, Medicaid Dual Eligibles, and Medicare reimbursement and enrollment; Issues related to Drug Pricing and rebates, including Part D reform. Issues related to coronavirus response.
Medicare advantage payment policy. Issues related to the federal response to Covid-19.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA INC via CAPITOL HILL CONSULTING GROUP
2021 · first_quarter · Q1
Issues related to the response of the COVID-19 virus and access to vaccines.
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Issues surrounding the reintroduction of BETTER Kidney Care Act Issues related to the HHS Provider Relief Fund.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2021 · first_quarter · Q1
Monitoring for issues and hearing related to prevention of abuse, misuse or diversion of prescription drugs; federal response to the COVID-19 crisis; prescription drug payment reform; and pharmaceutical supply chain.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEVA PHARMACEUTICALS USA via CAPITOL HILL CONSULTING GROUP
2020 · second_quarter · Q2
Issues surrounding US Pharmaceutical supply chain
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COHERUS BIOSCIENCES, INC via CAPITOL HILL CONSULTING GROUP
2020 · fourth_quarter · 4A
Medicare and Medicaid reimbursement for biosimilars.
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
TEVA PHARMACEUTICALS USA via CAPITOL HILL CONSULTING GROUP
2020 · fourth_quarter · Q4
Issues surrounding US Pharmaceutical supply chain
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES PHARMACOPEIAL CONVENTION (USP) via CAPITOL HILL CONSULTING GROUP
2020 · fourth_quarter · Q4
Maintaining US support for quality pharmaceutical standards. Issues related to coronavirus, including drug and supply chain safety. Issues related to continuous manufacturing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
AMERICAN CHIROPRACTIC ASSOCIATION, INC. via CAPITOL HILL CONSULTING GROUP
2020 · fourth_quarter · Q4
Medicare reimbursement and coverage of chiropractic services, including H.R. 3654. Issues related to coronavirus, including regulatory flexibility for providers. Issues related to expanding access through telehealth. Issues related to the HHS Provider Relief Fund. Issues related to physician reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN PODIATRIC MEDICAL ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2020 · fourth_quarter · Q4
Issues related to H.R. 2235 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act. Issues related to therapeutic shoes. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund Issues regarding physician reimbursement
Issues related to S. 863 to clarify the VA Provider Equity Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASSOCIATION OF AMERICAN MEDICAL COLLEGES via CAPITOL HILL CONSULTING GROUP
2020 · fourth_quarter · Q4
Issues related to the cost of health coverage; Issues related to Surprise Billing; Issues related to Covid-19.
Issues related to Graduate Medical Education.Issues related to price transparency. Issues related to H.R. 1763. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY GENERIC PHARMACEUTICAL ASSOC.) via CAPITOL HILL CONSULTING GROUP
2020 · fourth_quarter · Q4
Provisions from the Bipartisan Budget Act of 2015 concerning the Medicaid rebate program. Issues related to the Medicare low-income subsidy. Issues related to the cost of prescription drugs. Issues pertaining to coverage and reimbursement of biosimilars. Issues related to Part D coverage of generic drugs, including Part D redesign.
- Issues relating to bioequivalence and related administrative procedures. - Issues relating to prescription drug abuse. - Issues relating to the labeling of generic drugs. - Issues relating to the Lower Health Care Costs Act, including 180 day exclusivity for generics. - Issues related to coronavirus, including supply chain safety.
CVS PREVIOUSLY AETNA via CAPITOL HILL CONSULTING GROUP
2020 · fourth_quarter · Q4
Issues pertaining to entitlement reform, Medicare Advantage, Medicaid Dual Eligibles, and Medicare reimbursement and enrollment; Issues related to Drug Pricing and rebates, including Part D reform. Issues related to coronavirus response. Issues related to telehealth reimbursement.
Issues related to surprise billing. Medicare advantage payment policy. Issues related to the federal response to Covid-19.
Issues related to Public Law 111-148 - The Patient Protection and Affordable Care Act; Issues related to Public Law 111-152 - Health Care and Education Reconciliation Act of 2010; Issues related to the Affordable Care Act's implementation, including Medical Loss Ratio, taxes, Exchanges, Essential health Benefits, premium affordability, health information technology, transparency, and employer regulations.
DAVITA INC via CAPITOL HILL CONSULTING GROUP
2020 · fourth_quarter · Q4
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Issues related to improvement of chronic disease. Issues surrounding H.R. 8254 / S. 4574 the BETTER Kidney Care Act Issues related to the HHS Provider Relief Fund.
Issues related to response of the COVID-19 virus.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2020 · fourth_quarter · Q4
Monitoring for issues and hearing related to prevention of abuse, misuse or diversion of prescription drugs; federal response to the COVID-19 crisis; prescription drug payment reform; and pharmaceutical supply chain.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COHERUS BIOSCIENCES, INC via CAPITOL HILL CONSULTING GROUP
2020 · fourth_quarter · 4A
Medicare and Medicaid reimbursement for biosimilars.
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
COHERUS BIOSCIENCES, INC via CAPITOL HILL CONSULTING GROUP
2020 · fourth_quarter · Q4
Medicare and Medicaid reimbursement for biosimilars.
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
AMERICAN CHIROPRACTIC ASSOCIATION, INC. via CAPITOL HILL CONSULTING GROUP
2020 · third_quarter · 3A
Medicare reimbursement and coverage of chiropractic services, including H.R. 3654. Issues related to coronavirus, including regulatory flexibility for providers. Issues related to expanding access through telehealth. Issues related to the HHS Provider Relief Fund.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COHERUS BIOSCIENCES, INC via CAPITOL HILL CONSULTING GROUP
2020 · third_quarter · Q3
Medicare and Medicaid reimbursement for biosimilars.
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
TEVA PHARMACEUTICALS USA via CAPITOL HILL CONSULTING GROUP
2020 · third_quarter · Q3
Issues surrounding US Pharmaceutical supply chain
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES PHARMACOPEIAL CONVENTION (USP) via CAPITOL HILL CONSULTING GROUP
2020 · third_quarter · Q3
Maintaining US support for quality pharmaceutical standards. Issues related to coronavirus, including drug and supply chain safety. Issues related to continuous manufacturing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
UNITED STATES PHARMACOPEIAL CONVENTION (USP) via CAPITOL HILL CONSULTING GROUP
2020 · third_quarter · Q3
Maintaining US support for quality pharmaceutical standards. Issues related to coronavirus, including drug and supply chain safety. Issues related to continuous manufacturing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
AMERICAN PODIATRIC MEDICAL ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2020 · third_quarter · Q3
Issues related to H.R. 2235 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act. Issues related to therapeutic shoes. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund Issues regarding physician reimbursement
Issues related to S. 863 to clarify the VA Provider Equity Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASSOCIATION OF AMERICAN MEDICAL COLLEGES via CAPITOL HILL CONSULTING GROUP
2020 · third_quarter · Q3
Issues related to the cost of health coverage; Issues related to Surprise Billing; Issues related to Covid-19.
Issues related to Graduate Medical Education.Issues related to price transparency. Issues related to H.R. 1763. Issues related to coronavirus, including funding and regulatory flexibility for providers. Issues related to the HHS Provider Relief Fund.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY GENERIC PHARMACEUTICAL ASSOC.) via CAPITOL HILL CONSULTING GROUP
2020 · third_quarter · Q3
Issues related to Buy American.
- Issues relating to bioequivalence and related administrative procedures. - Issues relating to prescription drug abuse. - Issues relating to the labeling of generic drugs. - Issues relating to the Lower Health Care Costs Act, including 180 day exclusivity for generics. - Issues related to coronavirus, including supply chain safety.
Provisions from the Bipartisan Budget Act of 2015 concerning the Medicaid rebate program. Issues related to the Medicare low-income subsidy. Issues related to the cost of prescription drugs. Issues pertaining to coverage and reimbursement of biosimilars. Issues related to Part D coverage of generic drugs, including Part D redesign.
CVS PREVIOUSLY AETNA via CAPITOL HILL CONSULTING GROUP
2020 · third_quarter · Q3
Issues related to Public Law 111-148 - The Patient Protection and Affordable Care Act; Issues related to Public Law 111-152 - Health Care and Education Reconciliation Act of 2010; Issues related to the Affordable Care Act's implementation, including Medical Loss Ratio, taxes, Exchanges, Essential health Benefits, premium affordability, health information technology, transparency, and employer regulations.
Health Insurance Tax Repeal. Implementation of Tax Cuts and Jobs Act. Deductibility of executive compensation.
Issues related to surprise billing. Medicare advantage payment policy. Issues related to the federal response to Covid-19.
DAVITA INC via CAPITOL HILL CONSULTING GROUP
2020 · third_quarter · Q3
Issues related to response of the COVID-19 virus.
Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Issues related to improvement of chronic disease. Issues surrounding H.R. 8254 / S. 4574 the BETTER Kidney Care Act Issues related to the HHS Provider Relief Fund.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2020 · third_quarter · Q3
Monitoring for issues related to prevention of abuse, misuse or diversion of prescription drugs; federal response to the COVID-19 crisis; prescription drug payment reform; and pharmaceutical supply chain.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COHERUS BIOSCIENCES, INC via CAPITOL HILL CONSULTING GROUP
2020 · third_quarter · RR
Medicare Reimbursement for biosimilars.
Medicare Reimbursement for biosimilars.
Generic Drug User Fee Amendments (GDUFA)
- Issues relating to the labeling of generic drugs. - Issues relating to the 180 day exclusivity for generics. - Issues related to medical supply chain, including supply chain safety. - Issues related to drug pricing including drug negotiation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Buy American.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Buy American.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues pertaining to entitlement reform, Medicare Advantage, Medicaid Dual Eligibles, and Medicare reimbursement and enrollment; Issues related to Drug Pricing and rebates, including Part D reform. Issues related to coronavirus response.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE